查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1881800

融合切片市场－全球产业规模、份额、趋势、机会及预测，依切片途径（经直肠、经会阴）、最终用户（医院、诊断中心、门诊中心）、区域及竞争格局划分，2020-2030年预测

Fusion Biopsy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Biopsy Route (Transrectal, Transperineal), By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球融合切片市场规模为6.1892亿美元，预计2030年将以8.6%的复合年增长率成长至10.1534亿美元。融合活检是一种先进的诊断技术，它将磁振造影与即时超音波结合，能够精准定位可疑病灶进行组织取样，主要用于前列腺部位。此方法透过引导活检针到达特定异常区域，显着提高了诊断准确性，优于传统的随机取样。前列腺癌在全球范围内日益增长的发病率以及影像技术的不断进步（提高了检测率和手术精度）是推动融合活检市场发展的主要因素。

市场概览
预测期 2026-2030
2024年市场规模 6.1892亿美元
2030年市场规模 10.1534亿美元
2025-2030年复合年增长率 8.6%
成长最快的细分市场 经直肠
最大的市场 北美洲

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球融合切片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 经由切片途径（经直肠、经会阴）
    • 依最终使用者（医院、诊断中心、门诊中心）划分
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美融合切片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲融合切片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区融合切片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲融合活检市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲融合切片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购（如有）
  • 产品发布（如有）
  • 最新进展

第十三章：全球融合切片市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Eigen Health Ltd
  • Koninklijke Philips NV
  • Hitachi, Ltd.
  • MedCom Inc
  • Esaoate SpA
  • KOELIS SAS
  • Focal Healthcare Inc
  • UC-Care Medical Systems Ltd.
  • GeoScan Medical

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 21001

The Global Fusion Biopsy Market, valued at USD 618.92 Million in 2024, is projected to experience a CAGR of 8.6% to reach USD 1015.34 Million by 2030. Fusion biopsy is an advanced diagnostic technique that integrates magnetic resonance imaging with real-time ultrasound to precisely target suspicious lesions for tissue sampling, predominantly within the prostate. This method enhances diagnostic accuracy by guiding the biopsy needle to specific abnormal areas, a considerable improvement over traditional random sampling. The market for fusion biopsy is significantly driven by the increasing global prevalence of prostate cancer and continuous advancements in imaging technologies that improve detection and procedural precision.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 618.92 Million
Market Size 2030USD 1015.34 Million
CAGR 2025-20308.6%
Fastest Growing SegmentTransrectal
Largest MarketNorth America

Key Market Drivers

The increasing global prevalence of prostate cancer is a primary market driver, fueling demand for precise diagnostic tools. With new diagnoses consistently rising, advanced detection methods are critical for improved patient outcomes. According to the International Agency for Research on Cancer's Global Cancer Observatory, in 2022, approximately 1.5 million new cases of prostate cancer were reported globally, underscoring this persistent demand. Simultaneously, continuous advancements in medical imaging technologies significantly impact market expansion. Improvements in MRI and ultrasound systems, with sophisticated software, enhance fusion biopsy precision. These technological evolutions enable more accurate lesion identification.

Key Market Challenges

The elevated cost associated with fusion biopsy systems and procedures, alongside challenges in securing comprehensive reimbursement, significantly impedes market expansion. The high capital investment required for these advanced diagnostic platforms creates a substantial financial burden for healthcare providers. This limitation particularly affects institutions with restricted budgets and healthcare systems in developing economies, curtailing their ability to acquire and implement fusion biopsy technology.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning is a significant trend transforming the global fusion biopsy market by enhancing diagnostic accuracy and procedural efficiency. AI algorithms analyze complex imaging data, such as MRI, to identify suspicious lesions with greater precision, reducing inter-operator variability and potentially lowering healthcare costs. This technological advancement also facilitates more efficient workflows, with AI systems capable of optimizing lesion segmentation and image texture analysis.

Key Market Players

  • Eigen Health Ltd
  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • MedCom Inc
  • Esaoate SpA
  • KOELIS SAS
  • Focal Healthcare Inc
  • UC-Care Medical Systems Ltd.
  • GeoScan Medical

Report Scope:

In this report, the Global Fusion Biopsy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fusion Biopsy Market, By Biopsy Route:

  • Transrectal
  • Transperineal

Fusion Biopsy Market, By End-User:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers

Fusion Biopsy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Fusion Biopsy Market.

Available Customizations:

Global Fusion Biopsy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fusion Biopsy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Biopsy Route (Transrectal, Transperineal)
    • 5.2.2. By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Fusion Biopsy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Biopsy Route
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fusion Biopsy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Biopsy Route
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Fusion Biopsy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Biopsy Route
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Fusion Biopsy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Biopsy Route
        • 6.3.3.2.2. By End-User

7. Europe Fusion Biopsy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Biopsy Route
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fusion Biopsy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Biopsy Route
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Fusion Biopsy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Biopsy Route
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Fusion Biopsy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Biopsy Route
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Fusion Biopsy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Biopsy Route
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Fusion Biopsy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Biopsy Route
        • 7.3.5.2.2. By End-User

8. Asia Pacific Fusion Biopsy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Biopsy Route
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fusion Biopsy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Biopsy Route
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Fusion Biopsy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Biopsy Route
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Fusion Biopsy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Biopsy Route
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Fusion Biopsy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Biopsy Route
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Fusion Biopsy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Biopsy Route
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Fusion Biopsy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Biopsy Route
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fusion Biopsy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Biopsy Route
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Fusion Biopsy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Biopsy Route
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Fusion Biopsy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Biopsy Route
        • 9.3.3.2.2. By End-User

10. South America Fusion Biopsy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Biopsy Route
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fusion Biopsy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Biopsy Route
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Fusion Biopsy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Biopsy Route
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Fusion Biopsy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Biopsy Route
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fusion Biopsy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eigen Health Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Koninklijke Philips N.V.
  • 15.3. Hitachi, Ltd.
  • 15.4. MedCom Inc
  • 15.5. Esaoate SpA
  • 15.6. KOELIS SAS
  • 15.7. Focal Healthcare Inc
  • 15.8. UC-Care Medical Systems Ltd.
  • 15.9. GeoScan Medical

16. Strategic Recommendations

17. About Us & Disclaimer